Starting dose in cancer patients

From: Venkat Pokiri Date: September 27, 2007 technical Source: mail-archive.com

Dear all; I am just wondering whether any regulatory (FDA, MHRA etc. ) guidance available on the starting dose of molecular targeted therapy (MTT) agents such as tyrosine kinase inhibitors in cancer patients. I would appreciate your thoughts on this topic. Best regards, VPokiri >

← Previous

`j` / `k`	Next / previous message
`o`	Open message
`f`	Search
`s`	Copy link
`t`	Filters
`c`	Copy message body
`r`	Related threads
`?`	This help
`Esc`	Close / clear